These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38123343)

  • 1. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
    Okamura T; Tsukamoto K; Arai H; Fujioka Y; Ishigaki Y; Koba S; Ohmura H; Shoji T; Yokote K; Yoshida H; Yoshida M; Deguchi J; Dobashi K; Fujiyoshi A; Hamaguchi H; Hara M; Harada-Shiba M; Hirata T; Iida M; Ikeda Y; Ishibashi S; Kanda H; Kihara S; Kitagawa K; Kodama S; Koseki M; Maezawa Y; Masuda D; Miida T; Miyamoto Y; Nishimura R; Node K; Noguchi M; Ohishi M; Saito I; Sawada S; Sone H; Takemoto M; Wakatsuki A; Yanai H
    J Atheroscler Thromb; 2024 Jun; 31(6):641-853. PubMed ID: 38123343
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(7):603-15. PubMed ID: 23883545
    [No Abstract]   [Full Text] [Related]  

  • 3. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.
    Kinoshita M; Yokote K; Arai H; Iida M; Ishigaki Y; Ishibashi S; Umemoto S; Egusa G; Ohmura H; Okamura T; Kihara S; Koba S; Saito I; Shoji T; Daida H; Tsukamoto K; Deguchi J; Dohi S; Dobashi K; Hamaguchi H; Hara M; Hiro T; Biro S; Fujioka Y; Maruyama C; Miyamoto Y; Murakami Y; Yokode M; Yoshida H; Rakugi H; Wakatsuki A; Yamashita S;
    J Atheroscler Thromb; 2018 Sep; 25(9):846-984. PubMed ID: 30135334
    [No Abstract]   [Full Text] [Related]  

  • 4. Women. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):291-5. PubMed ID: 24335044
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):850-60. PubMed ID: 24335039
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(12):835-49. PubMed ID: 24172256
    [No Abstract]   [Full Text] [Related]  

  • 7. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2013; 20(6):517-23. PubMed ID: 23665881
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):93-8. PubMed ID: 24335040
    [No Abstract]   [Full Text] [Related]  

  • 9. Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):86-92. PubMed ID: 24335038
    [No Abstract]   [Full Text] [Related]  

  • 10. Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2014; 21(2):82-5. PubMed ID: 24335037
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M;
    J Atheroscler Thromb; 2007 Aug; 14(4):155-8. PubMed ID: 17827859
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Dec; 14(6):267-77. PubMed ID: 18176013
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of atherosclerosis. Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan―2012 Version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K;
    J Atheroscler Thromb; 2014; 21(4):296-8. PubMed ID: 24335045
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012.
    Tada H; Kawashiri MA; Nohara A; Inazu A; Kobayashi J; Yasuda K; Mabuchi H; Yamagishi M; Hayashi K
    J Atheroscler Thromb; 2017 Mar; 24(3):338-345. PubMed ID: 27568728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version.
    Teramoto T; Sasaki J; Ishibashi S; Birou S; Daida H; Dohi S; Egusa G; Hiro T; Hirobe K; Iida M; Kihara S; Kinoshita M; Maruyama C; Ohta T; Okamura T; Yamashita S; Yokode M; Yokote K
    J Atheroscler Thromb; 2013; 20(10):733-42. PubMed ID: 23892529
    [No Abstract]   [Full Text] [Related]  

  • 16. [Present Execution of and Problems with Clinical Lipid Examination and Application of "the Japan Atherosclerotic Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2012"].
    Igarashi M; Tanji Y; Nomura T; Yamaguchi H
    Rinsho Byori; 2014 Sep; 62(9):884-91. PubMed ID: 27526534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.
    Teramoto T; Sasaki J; Ueshima H; Egusa G; Kinoshita M; Shimamoto K; Daida H; Biro S; Hirobe K; Funahashi T; Yokote K; Yokode M
    J Atheroscler Thromb; 2007 Apr; 14(2):45-50. PubMed ID: 17485887
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum Lipid Goal Attainment in Chronic Kidney Disease (CKD) Patients under the Japan Atherosclerosis Society (JAS) 2012 Guidelines.
    Shimizu R; Torii H; Yasuda D; Hiraoka Y; Kitada N; Hashida T; Yoshimoto A; Kita T; Kume N
    J Atheroscler Thromb; 2015; 22(9):949-57. PubMed ID: 25843151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid intima-media thickness and plaque in apparently healthy Japanese individuals with an estimated 10-year absolute risk of CAD death according to the Japan Atherosclerosis Society (JAS) guidelines 2012: the Shiga Epidemiological Study of Subclinical Atherosclerosis (SESSA).
    Kadota A; Miura K; Okamura T; Fujiyoshi A; Ohkubo T; Kadowaki T; Takashima N; Hisamatsu T; Nakamura Y; Kasagi F; Maegawa H; Kashiwagi A; Ueshima H; ;
    J Atheroscler Thromb; 2013; 20(10):755-66. PubMed ID: 23831585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Achievement Rates for Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Atherosclerotic Cardiovascular Disease in a Real-World Setting in Japan.
    Mitani H; Suzuki K; Ako J; Iekushi K; Majewska R; Touzeni S; Yamashita S
    J Atheroscler Thromb; 2023 Nov; 30(11):1622-1634. PubMed ID: 36928267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.